• Categories

Indigo Announces New Integration Partnership with Shimadzu

6/18/2014

Shimadzu and Indigo BioSystems partner to leverage the power of ASCENT™ clinical solutions on ultra-fast mass spectrometry platforms

INDIANAPOLIS, June 18, 2014 – Indigo Biosystems and Shimadzu have announced a partnership to develop and market mass spectrometry solutions that simplify and accelerate clinical data acquisition and data review for applications in clinical research, forensic toxicology and new drug development.

Indigo’s ASCENT software supports the scientist by automatically analyzing and reporting correct data, and flagging only the outliers for expert review. ASCENT speeds sample analysis by automating peak selection and peak area fitting. ASCENT also includes assay-specific quality assurance rules, which allow peaks to be automatically tested for quality. It operates using a web-browser interface requiring no software to be installed on computers in order to perform quantitative analysis. ASCENT clinical analysis software is a comprehensive and powerful data analysis suite that interprets visual data results from instruments and automatically reviews the data for problematic results. Results are delivered quickly, consistently, and reliably.

This collaboration will combine Shimadzu’s ultra-fast mass spectrometry platforms with the ASCENT data analysis software for a completely integrated experience. Having a seamless connection between the powerful ultra-fast mass spectrometers and a state-of-the-art software will simplify workflow and improve efficiency.

Patrick Armstrong, Director of Shimadzu Scientific Instrument’s R&D department said, “Indigo BioSystems’ tools for high-throughput, automated data analysis are highly developed with an impressive list of advanced features, and greatly simplify clinical laboratory workflows,” adding that, “We are excited to work with Indigo to leverage powerful ASCENT tools on Shimadzu ultra-fast mass spectrometry platforms”.

ASCENT supports the scientist by automatically analyzing and reporting correct data, and flagging only the outliers for expert review. ASCENT speeds sample analysis by automating peak selection and peak area fitting. ASCENT also includes assay-specific quality assurance rules, which allow peaks to be automatically tested for quality. ASCENT operates using a web-browser interface requiring no software to be installed on computers in order to perform quantitative analysis.

Dr. Randall Julian, CEO of Indigo BioSystems said, “Our partnership with Shimadzu will result in tighter integration between their excellent ultra-fast LC-MS/MS and our automated analysis software ASCENT. This collaboration allows production labs to achieve maximum efficiency, superior quality, and rapid turnaround time. Shimadzu instruments, in combination with the ASCENT software, create a high-throughput, intelligent, production system.”

About Shimadzu Corporation

Founded in 1875, Shimadzu Corporation, a leader in the development of advanced technologies, has a distinguished history of innovation built on the foundation of contributing to society through science and technology. Shimadzu maintains a global network of sales, service, technical support and applications centers on six continents, and has established long-term relationships with a host of highly trained distributors located in over 100 countries. For more information, visit www.shimadzu.com.